Pregled bibliografske jedinice broj: 21146
3-Hydroxyquinuclidinium derivatives: reversible and acylating inhibitors of acetylcholinesterase
3-Hydroxyquinuclidinium derivatives: reversible and acylating inhibitors of acetylcholinesterase // Third International Meeting on Esterases Reacting with Organophosphorus Compounds, Dubrovnik, Programme and Abstracts / Reiner, Elsa (ur.).
Zagreb: Institut za medicinska istraživanja i medicinu rada, 1998. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 21146 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
3-Hydroxyquinuclidinium derivatives: reversible and acylating inhibitors of acetylcholinesterase
Autori
Reiner, Elsa ; Škrinjarić-Špoljar, Mira ; Dunaj, Sanja ; Buntić, Anđelka ; Simeon-Rudolf, Vera
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Third International Meeting on Esterases Reacting with Organophosphorus Compounds, Dubrovnik, Programme and Abstracts
/ Reiner, Elsa - Zagreb : Institut za medicinska istraživanja i medicinu rada, 1998
Skup
Third International Meeting on Esterases Reacting with Organophosphorus Compounds
Mjesto i datum
Dubrovnik, Hrvatska, 15.04.1998. - 18.04.1998
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Quinuclidinium-imidazolium compounds; Quinuclidinium carbamates; Reversible and progressive acetylcholinesterase inhibition; Reaction of acetylthiocholine with quinuclidinium carbamates
Sažetak
Four compounds were tested for their inhibitory effect on acetylcholinesterase (EC 3.1.1.7): 3-hydroxy-N-methylquinuclidinium N-(3-(2-iodide(I), N-[3-(3-methyl-2-hydroxyiminomethyl-1-imidazolio)-2-oxa-propyl]-3-hydroxyquinuclidinium dichloride (II)and the dimethyl-carbamates of the compounds I and II (compounds III and IV respectively). Native human erythrocytes were the enzyme source and the activity was measured in 0.1 M phosphate buffer pH = 7.4 with acetylthiocholine (ATCh) as the substrate. The enzyme/inhibitor dissociation constants were evaluated from the apparent issociation constants as function of the ATCh concentration (0.05-1.0 mM). All compounds were reversible inhibitors of AChE and the dissociation constants were between 0.2 and 0.5 mM. Compounds III and IV were also acylating AChE inhibitors. The oxime group in the compounds II and IV hydrolysed ATCh at a rate which interferred with the enzyme catalysed hydrolysis of ATCh. In order to slow down the ATCh/oxime reaction, reversible inhibition by the compounds II and IV was also measured at a low temperature.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
00220104
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb